COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis

Author(s)

Faria, M. S. M. S. ; Shinjo, S. K.

• Document type: Journal article
• Source: REUMATISMO; v. 74, n. 1, p. 3-pg., 2022-01-01.

Abstract

Borges et al. have recently reported the first case of a dermatomyositis onset in close association with established coronavirus disease 2019 (COVID-19). Similarly, we report a patient who, on the contrary, had COVID-19 following early established dermatomyositis. We report prospectively the outcome of her disease. (AU)

• FAPESP's process: 19/11776-6 - Impact and safety of noninvasive cerebral neuromodulation in patients with systemic autoimmune diseases: double-blind, randomized, placebo-controlled study
• Grantee: Samuel Katsuyuki Shinjo
• Support Opportunities: Regular Research Grants